Bacterioboat—A novel tool to increase the half-life period of the orally administered drug

The short half-life in the GI tract necessitates an excess of drugs causing side effects of oral formulations. Here, we report the development and deployment of Bacterioboat, which consists of surface-encapsulated mesoporous nanoparticles on metabolically active Lactobacillus reuteri as a drug carri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Parmandeep, Ghosh, Sandip, Bhowmick, Arghya, Gadhave, Kundlik, Datta, Satabdi, Ghosh, Abhrajyoti, Garg, Neha, Mahajan, Roop L., Basu, Biswarup, Choudhury, Diptiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916724/
https://www.ncbi.nlm.nih.gov/pubmed/35275724
http://dx.doi.org/10.1126/sciadv.abh1419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916724/
https://www.ncbi.nlm.nih.gov/pubmed/35275724
http://dx.doi.org/10.1126/sciadv.abh1419

Ejemplares similares